A Treatable Systemic Muscle Disease



Fig. 40.1
There is an endomysial inflammatory infiltrate with infiltration of non-necrotic fibres by lymphocytes (a, b, arrows). There is variation in fibre size and fibre necrosis (b, *). The lymphocytic infiltrate is composed predominantly of T-cells (c) and these can be confirmed to have invaded viable fibres (d, arrow). MHC class I is expressed on the sarcolemma and often in the sarcoplasm of fibres (e). (a, b): Haematoxylin and eosin; (c, d): CD3 immunohistochemistry; (e): MHC class I immunohistochemistry. Bar in (a) represents 50 μm in (a, c, e) and 25 μm in (b, d) (Image courtesy of Zane Jaunmuktane and Sebastian Brandner)



A chest x-ray and whole body FDG-PET were normal.



Diagnosis


Polymyositis.


Discussion


The patient was treated with 3 days of 1 g methylprednisolone followed by oral prednisolone 60 mg o.d. and azathioprine 50 mg od (TPMT normal). Azathioprine caused raised liver function tests, and was replaced with mycophenolate mofetil. Corticosteroids were slowly tapered and she was maintained on mycophenolate mofetil monotherapy at 1 g b.d. She has continued to make gradual functional improvement.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 15, 2017 | Posted by in NEUROLOGY | Comments Off on A Treatable Systemic Muscle Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access